Use of transfected or transduced mammalian cells for...

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 48/00 (2006.01) A61K 38/17 (2006.01) A61K 38/18 (2006.01) A61K 38/19 (2006.01) A61K 38/20 (2006.01) A61K 38/30 (2006.01)

Patent

CA 2308511

Disclosed is the use of vectors such as adenoviruses and/or adeno associated viruses and/or retroviruses and/or Herpes Simplex viruses and/or liposomes and/or plasmids as agents which stimulate mammal cells in order to produce therapeutic proteins that act as medicaments on a cellular level for the genetic treatment of bone pathologies.

L'invention concerne l'utilisation de vecteurs tels que adénovirus et/ou virus-adéno associés et/ou rétrovirus et/ou herpèsvirus et/ou liposomes et/ou plasmides, comme agents stimulant les cellules de mammifères en vue de la production de protéines thérapeutiques, agissant comme médicaments, au niveau cellulaire, pour le traitement génétique de pathologies osseuses.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Use of transfected or transduced mammalian cells for... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Use of transfected or transduced mammalian cells for..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of transfected or transduced mammalian cells for... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-2028854

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.